Shanghai MicuRx Pharmaceuticals (Stock code: 688373) has successfully listed on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange.

The company issued 130 million shares to the public at a price of 8.16 yuan per share. The total amount of new shares raised was 1.0608 billion RMB. After the issuance, the total share capital was 655,210,100 shares.

The company’s main business is to discover, develop and commercialize innovative unmeet clinical drugs . The funds raised this time are mainly used for innovative drug research and development, marketing channel upgrading, academic promotion, supplement of working capital and other projects.